These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

677 related items for PubMed ID: 2297729

  • 1. Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens.
    Sharkey RM, Gold DV, Aninipot R, Vagg R, Ballance C, Newman ES, Ostella F, Hansen HJ, Goldenberg DM.
    Cancer Res; 1990 Feb 01; 50(3 Suppl):828s-834s. PubMed ID: 2297729
    [Abstract] [Full Text] [Related]

  • 2. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.
    Blumenthal RD, Sharkey RM, Haywood L, Natale AM, Wong GY, Siegel JA, Kennel SJ, Goldenberg DM.
    Cancer Res; 1992 Nov 01; 52(21):6036-44. PubMed ID: 1394228
    [Abstract] [Full Text] [Related]

  • 3. Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts.
    Sharkey RM, Motta-Hennessy C, Pawlyk D, Siegel JA, Goldenberg DM.
    Cancer Res; 1990 Apr 15; 50(8):2330-6. PubMed ID: 2180566
    [Abstract] [Full Text] [Related]

  • 4. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms.
    Yokota T, Milenic DE, Whitlow M, Wood JF, Hubert SL, Schlom J.
    Cancer Res; 1993 Aug 15; 53(16):3776-83. PubMed ID: 8339291
    [Abstract] [Full Text] [Related]

  • 5. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
    Temponi M, Gold AM, Ferrone S.
    Cancer Res; 1992 May 01; 52(9):2497-503. PubMed ID: 1373670
    [Abstract] [Full Text] [Related]

  • 6. Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alpha.
    Robert B, Mach JP, Mani JC, Ychou M, Folli S, Artus JC, Pèlegrin A.
    Cancer Res; 1996 Oct 15; 56(20):4758-65. PubMed ID: 8840995
    [Abstract] [Full Text] [Related]

  • 7. Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.
    Buchegger F, Pfister C, Fournier K, Prevel F, Schreyer M, Carrel S, Mach JP.
    J Clin Invest; 1989 May 15; 83(5):1449-56. PubMed ID: 2708519
    [Abstract] [Full Text] [Related]

  • 8. Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
    Sharkey RM, Karacay H, Richel H, McBride WJ, Rossi EA, Chang K, Yeldell D, Griffiths GL, Hansen HJ, Goldenberg DM.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 2):3897S-913S. PubMed ID: 14506188
    [Abstract] [Full Text] [Related]

  • 9. Regional and systemic distribution of anti-tumor x anti-CD3 heteroaggregate antibodies and cultured human peripheral blood lymphocytes in a human colon cancer xenograft.
    Nelson H, Ramsey PS, Kerr LA, McKean DJ, Donohue JH.
    J Immunol; 1990 Nov 15; 145(10):3507-15. PubMed ID: 1700013
    [Abstract] [Full Text] [Related]

  • 10. Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49.
    Milenic DE, Yokota T, Filpula DR, Finkelman MA, Dodd SW, Wood JF, Whitlow M, Snoy P, Schlom J.
    Cancer Res; 1991 Dec 01; 51(23 Pt 1):6363-71. PubMed ID: 1933899
    [Abstract] [Full Text] [Related]

  • 11. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.
    Yokota T, Milenic DE, Whitlow M, Schlom J.
    Cancer Res; 1992 Jun 15; 52(12):3402-8. PubMed ID: 1596900
    [Abstract] [Full Text] [Related]

  • 12. Murine monoclonal antibodies raised against human non-small cell carcinoma of the lung: specificity and tumor targeting.
    Stein R, Chen S, Sharkey RM, Goldenberg DM.
    Cancer Res; 1990 Feb 15; 50(4):1330-6. PubMed ID: 2153458
    [Abstract] [Full Text] [Related]

  • 13. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ, Rogers BE, Khazaeli MB, Mayo MS, Milenic DE, Kashmiri SV, Anderson CJ, Chappell LL, Brechbiel MW, Curiel DT.
    Clin Cancer Res; 1999 Oct 15; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [Abstract] [Full Text] [Related]

  • 14. Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.
    Sutherland R, Buchegger F, Schreyer M, Vacca A, Mach JP.
    Cancer Res; 1987 Mar 15; 47(6):1627-33. PubMed ID: 3545451
    [Abstract] [Full Text] [Related]

  • 15. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM, Béhé M, Stabin MG, Wehrmann E, Apostolidis C, Molinet R, Strutz F, Fayyazi A, Wieland E, Gratz S, Koch L, Goldenberg DM, Becker W.
    Cancer Res; 1999 Jun 01; 59(11):2635-43. PubMed ID: 10363986
    [Abstract] [Full Text] [Related]

  • 16. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model.
    Iwahashi T, Okochi E, Ariyoshi K, Watabe H, Amann E, Mori S, Tsuruo T, Ono K.
    Cancer Res; 1993 Nov 15; 53(22):5475-82. PubMed ID: 8106147
    [Abstract] [Full Text] [Related]

  • 17. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model.
    Sharkey RM, Karacay H, Griffiths GL, Behr TM, Blumenthal RD, Mattes MJ, Hansen HJ, Goldenberg DM.
    Bioconjug Chem; 1997 Nov 15; 8(4):595-604. PubMed ID: 9258460
    [Abstract] [Full Text] [Related]

  • 18. Experimental and clinical analysis of the characteristics of a chimeric monoclonal antibody, MOv18, reactive with an ovarian cancer-associated antigen.
    Molthoff CF, Buist MR, Kenemans P, Pinedo HM, Boven E.
    J Nucl Med; 1992 Nov 15; 33(11):2000-5. PubMed ID: 1432162
    [Abstract] [Full Text] [Related]

  • 19. Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments.
    Casey JL, Pedley RB, King DJ, Green AJ, Yarranton GT, Begent RH.
    Br J Cancer; 1999 Nov 15; 81(6):972-80. PubMed ID: 10576653
    [Abstract] [Full Text] [Related]

  • 20. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
    Holton OD, Black CD, Parker RJ, Covell DG, Barbet J, Sieber SM, Talley MJ, Weinstein JN.
    J Immunol; 1987 Nov 01; 139(9):3041-9. PubMed ID: 3499463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.